Read More About Association Of British Neurologists Releases New guidelines For Multiple Sclerosis.
Your new post is loading...
Your new post is loading...
|
Krishan Maggon 's curator insight,
June 19, 2015 3:33 AM
NATURE | LETTER 日本語要約Drug-based modulation of endogenous stem cells promotes functional remyelination in vivoFadi J. Najm,Mayur Madhavan,Anita Zaremba,Elizabeth Shick,Robert T. Karl,Daniel C. Factor,Tyler E. Miller,Zachary S. Nevin,Christopher Kantor,Alex Sargent,Kevin L. Quick,Daniela M. Schlatzer,Hong Tang,Ruben Papoian,Kyle R. Brimacombe,Min Shen,Matthew B. Boxer,Ajit Jadhav,Andrew P. Robinson,Joseph R. Podojil,Stephen D. Miller,Robert H. Miller& Paul J. TesarAffiliationsContributionsCorresponding authorsNature 522, 216–220 (11 June 2015) doi:10.1038/nature14335Received 01 April 2014 Accepted 18 February 2015 Published online 20 April 2015
Krishan Maggon 's curator insight,
June 18, 2015 8:21 AM
SCIENTIFIC REPORTS | ARTICLE OPEN Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibodyWenjie Luo,Wencheng Liu,Xiaoyan Hu,Mary Hanna,April Caravaca& Steven M. PaulAffiliationsContributionsCorresponding authorsScientific Reports 5, Article number: 11161 doi:10.1038/srep11161Received 03 February 2015 Accepted 18 May 2015 Published 09 June 2015
Krishan Maggon 's curator insight,
June 11, 2015 12:20 AM
NATURE | LETTER HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammationVictoria A. Blaho,Sylvain Galvani,Eric Engelbrecht,Catherine Liu,Steven L. Swendeman,Mari Kono,Richard L. Proia,Lawrence Steinman,May H. Han& Timothy HlaAffiliationsContributionsCorresponding authorNature (2015) doi:10.1038/nature14462Received 16 March 2014 Accepted 08 April 2015 Published online 08 June 2015
Krishan Maggon 's curator insight,
May 14, 2015 3:22 AM
Sci Transl Med 13 May 2015:
Vol. 7, Issue 287, p. 287ra74 Sci. Transl. Med. DOI: 10.1126/scitranslmed.aaa8038RESEARCH ARTICLE MULTIPLE SCLEROSIS Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosisYonghao Cao1,*, Brittany A. Goods2,*, Khadir Raddassi1, Gerald T. Nepom3, William W. Kwok3,4,J. Christopher Love5,6,† and David A. Hafler1,6,†,‡+Author Affiliations 1Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT 06520, USA.2Department of Biological Engineering, Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA.3Benaroya Research Institute, Virginia Mason Research Center, Seattle, WA 98101, USA.4Department of Medicine, University of Washington, Seattle, WA 98101, USA.5Department of Chemical Engineering, Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 02139, USA.6The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.+Author Notes ↵* These authors contributed equally to this work. ↵† These authors contributed equally to this work. ↵‡Corresponding author. E-mail: david.hafler@yale.edu
The Yale-led team analyzed T cell populations from 23 MS patients and 22 healthy controls. Existing drugs target the MS-specific cytokines identified in the study and should be a promising new treatment for the disease, the authors say. http://news.yale.edu/2015/05/13/yale-researchers-solve-multiple-sclerosis-puzzle
Krishan Maggon 's curator insight,
May 5, 2015 5:50 AM
Citation: Fonteh AN, Ormseth C, Chiang J, Cipolla M, Arakaki X, et al. (2015) Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer’s Disease. PLoS ONE 10(5): e0125597. doi:10.1371/journal.pone.0125597 |